Cancer screening and early diagnosis in low and middle income countries Current situation and future perspectives

Limited health system capacities and competing health priorities in low and middle income countries (LMICs) necessitate apragmatic approach to population-based cancer screening. Thus, the challenges faced by LMICs to implement awestern' model of screening for common cancers and the possible means to overcome these challenges are presented. Breast cancer is the number one cancer with arising trend in the majority of LMICs. Implementation of mass-scale mammography-based screening is not feasible and sustainable in most of them. While some LMICs have introduced breast cancer screening based on clinical breast examination (CBE), the programs need to be of appropriate quality. All LMICs should improve the capacity for early diagnosis of breast cancer along with other common cancers through community education, training of frontline health workers, facilitating prompt referrals and improving the infrastructure for cancer diagnosis and treatment. Resources permitting, the LMICs with high burden of cervical cancer may consider human papillomavirus (HPV) detection-based screening; asimple low-cost alternative is visual inspection with acetic acid (VIA). Regardless of the choice, astrong linkage should be established between screening and treatment with implementation of robust quality assurance. The few LMICs with arising trend of colorectal cancers and adequate resources may implement demonstration projects to screen with fecal immunochemical tests (FIT). Oral cancer screening of habitual tobacco and/or alcohol users using oral visual examination (OVE) may be implemented in countries with high burden of the cancer, but primary prevention (i.e., tobacco/alcohol cessation) should be prioritized. Screenings for other cancers are not recommended for LMICs.